Davis Todd C Insider Trading Activity

Average Profitability
25.14%
Insider Buys Quantity
3
Insider Buys Sum
$644,509.30
Insider Sells Quantity
8
Insider Sells Sum
$6.2M

Insider Activity of Davis Todd C

Biography of Davis Todd C

No biography is available at this moment.

2025-05-09PurchaseLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
9,510
0.0497%
$105.20$1M+78.49%
2024-08-08PurchaseLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
2,500
0.014%
$97.39$243,481+13.49%
2023-09-22PurchaseLigand Pharmaceuticals Incorporated
LGND
CHIEF EXECUTIVE OFFICER
4,000
0.0232%
$59.38$237,529+25.54%
2018-10-08SaleLigand Pharmaceuticals Incorporated
LGND
director
2,500
0.0122%
$253.99$634,978-52.26%
2018-08-17SaleLigand Pharmaceuticals Incorporated
LGND
director
3,167
0.0145%
$239.50$758,497-49.82%
2018-08-16SaleLigand Pharmaceuticals Incorporated
LGND
director
5,833
0.0276%
$239.93$1.4M-48%
2018-02-27SaleLigand Pharmaceuticals Incorporated
LGND
director
12,335
0.0584%
$151.90$1.87M+13.07%
2018-02-26SaleLigand Pharmaceuticals Incorporated
LGND
director
4,835
0.0229%
$153.58$742,536+12.16%
2014-03-19SaleLigand Pharmaceuticals Incorporated
LGND
director
5,000
0.0249%
$79.63$398,147-28.76%
2014-03-18SaleLigand Pharmaceuticals Incorporated
LGND
director
2,500
0.0121%
$79.45$198,637-30.47%
2011-08-10PurchaseLigand Pharmaceuticals Incorporated
LGND
director
15,000
0.0745%
$10.90$163,500+24.71%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.